Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
ITAT Dismisses Tax Dept Appeal on ₹215 Cr Disputed Income for AY14–AY19 in Favor of Deepak Fertilisers
The Income-tax Appellate Tribunal (ITAT), Mumbai has dismissed appeals filed by the Income Tax Department against Deepak Fertilisers and Petrochemicals Corporation Ltd (DFPCL) for Assessment Years 2013-14 to 2018-19. This confirms earlier relief granted by the CIT(A) involving a disputed taxable income of ₹215 Crores. In addition, appeals filed by the company for AY 2015-16 and AY 2016-17 on specific issues were allowed in its favor for statistical purposes. The ₹215 Crore disputed taxable income represents approximately 18.5% of the company's TTM PAT of ₹1,164 Crores, removing a sizable contingent tax risk.
high confidence
What changedITAT dismissed the Tax Department's appeal, formally upholding the CIT(A)'s relief on ₹215 Crores of disputed income for AY 2013-14 through AY 2018-19.
Why it mattersEliminates potential tax liabilities on ₹215 Crores of income (~18.5% of TTM PAT), preventing potential cash outflows and resolving multi-year litigation.
Disputed Taxable Income: ₹ 215 CroresDisputed Income vs TTM PAT: ~18.5%Disputed Income vs Net Worth: ~6.0%Assessment Period: AY 2013-14 to AY 2018-19
📅 Short termPositive sentiment driver as an overhang of long-pending tax litigation involving ₹215 Crores is lifted.
📈 Long termStrengthens balance sheet clarity and reduces contingent legal liabilities, though core operational trajectory remains tied to specialty chemicals expansion and raw material prices.
⚠ Risk flags
The Income Tax Department retains the right to approach the High Court if substantial questions of law exist.
👀 What to Watch
Track whether the Income Tax Department files a further appeal before the High Court on substantial questions of law, and look for any reversal of provisions or notes to accounts in the upcoming Q3 FY27 disclosures.
Deepak Fertilisers Q2 FY27 Standalone PAT Falls 49% YoY to ₹25.6 Cr Despite 23% Revenue Rise
Deepak Fertilisers reported its unaudited standalone financial results for Q2 ended September 30, 2026. Standalone revenue from operations grew 22.7% YoY to ₹619.58 Cr compared to ₹504.95 Cr in Q2 FY26. However, net profit after tax declined sharply by 48.8% YoY to ₹25.60 Cr (vs ₹50.04 Cr in Q2 FY26), primarily impacted by a 55.1% rise in raw material consumption costs to ₹451.75 Cr. Standalone basic EPS fell to ₹2.03 from ₹3.96 in the year-ago period.
high confidence
What changedAnnouncement of Q2 and H1 FY27 unaudited standalone and consolidated financial results along with the statutory auditor's limited review report.
Why it mattersHigher material input costs severely compressed operating margins and standalone profitability, reflecting vulnerability to commodity and feedstock price volatility.
Standalone Revenue (Q2): ₹61,958 lakhsStandalone PAT (Q2): ₹2,560 lakhsCost of materials consumed (Q2): ₹45,175 lakhsStandalone EPS (Q2): ₹2.03Q2 Standalone Revenue vs TTM Revenue: ~5.1%
📅 Short termMargin contraction and falling standalone PAT are likely to keep the stock under pressure in the near term.
📈 Long termLong-term performance hinges on structural transition toward higher-margin specialty products and completion of upcoming capex facilities targeted by FY29.
⚠ Risk flags
Input cost inflation (material consumption up 55% YoY)
Feedstock dependency and ammonia market disruptions
Geopolitical headwinds and global tariff impacts
👀 What to Watch
Track management commentary on raw material cost inflation, ammonia pricing, and the margin trajectory of the specialty fertiliser (Croptek) and technical ammonium nitrate (TAN) segments in the upcoming quarters.
Deepa Jewellers announced that Chief Financial Officer Mr. Srinivas Kamoji Gunupudi has resigned due to personal commitments, effective close of business on November 30, 2026. Concurrently, the company submitted its Monitoring Agency Report for the quarter ended September 30, 2026, prepared by CARE Ratings. The report confirms that out of ₹250.00 crore gross IPO proceeds raised in September 2026, ₹153.78 crore has been utilized with nil deviation from stated objects.
high confidence
What changedThe company's Chief Financial Officer has tendered his resignation effective November 30, 2026, and the Q2 FY27 IPO monitoring agency report was filed.
Why it mattersA CFO exit shortly after a September 2026 IPO warrants monitoring for leadership stability, though IPO proceeds deployment shows zero deviation according to CARE Ratings.
Gross IPO Proceeds: Rs. 250 croreProceeds Spent as of Sep 30, 2026: Rs. 153.78 croreDeviation from Objects: NilCFO Effective Resignation Date: November 30, 2026
📅 Short termShort-term focus will be on the smooth handover of the finance function and the appointment of an interim or permanent CFO before November 30, 2026.
📈 Long termLimited operational impact provided a qualified finance lead is appointed to manage post-IPO growth and capital allocation.
⚠ Risk flags
Key managerial personnel turnover within months of completing an IPO
👀 What to Watch
Track the announcement of the successor CFO and observe the scheduled deployment of the remaining ~₹96.22 crore of IPO proceeds in subsequent monitoring reports.
Deepak Nitrite Reports Record Q2 FY27 Revenue of ₹3,091 Cr, Up 61% YoY; Files Concall Transcript
Deepak Nitrite has submitted the transcript of its Q2 & H1 FY27 earnings conference call held on October 30, 2026. The company reported record consolidated revenue from operations of ₹3,091 crore for Q2 FY27, up 19% QoQ and 61% YoY, driven primarily by strong performance in the Phenolics segment. Toward the end of the quarter, Deepak Chemtech commissioned chlorination and specialty chemical assets in Dahej with a capex of approximately ₹300 crore. Additionally, progress continues on its integrated Polycarbonate project, including relocation and dismantling activities in Germany.
high confidence
What changedDeepak Nitrite published the official transcript of its Q2 & H1 FY27 earnings conference call.
Why it mattersProvides granular operational details on the record quarterly performance, newly commissioned specialty assets, and progress on major capex programs.
📅 Short termMarket reactions typically reflect the headline earnings already disclosed; the transcript clarifies near-term operational trends in Advanced Intermediates and Phenolics.
📈 Long termVertical integration from ammonia to amines and propylene to polycarbonate, alongside downstream solvents (MIBK/MIBC), is structurally expanding higher-margin specialty chemical exposure.
⚠ Risk flags
Global oversupply and pricing pressure from Chinese chemical producers
Execution and relocation risks associated with the Germany-to-India polycarbonate plant
👀 What to Watch
Track the commercial ramp-up and margin contributions from the newly commissioned ₹300 crore chlorination facility, along with execution timelines on the Polycarbonate project.
Deepak Nitrite Reports Highest-Ever Q2 FY27 PAT of ₹398 Cr (+235% YoY); Revenue Up 61% to ₹3,091 Cr
Deepak Nitrite delivered record financial results for Q2 FY27, with consolidated revenue rising 61% YoY to ₹3,091 crore and PAT surging 235% YoY to ₹398 crore. Growth was primarily driven by the Phenolics segment, where quarterly revenue surged 72% YoY to ₹2,291 crore and EBIT jumped 256% YoY to ₹515 crore due to favorable domestic spreads and import disruptions. The Advanced Intermediates segment saw a 38% YoY revenue increase to ₹811 crore, although margins faced global pricing pressure. Consolidated EBITDA margins expanded significantly to 20.8% in Q2 FY27 from 11.6% in Q2 FY26.
high confidence
What changedDeepak Nitrite released its Q2 & H1 FY27 investor presentation showcasing record quarterly revenue of ₹3,091 crore and record net profit of ₹398 crore.
Why it mattersA sharp rebound in domestic phenolics realization and volumes has dramatically expanded consolidated EBITDA margins from 11.6% to 20.8%, reversing previous margin headwinds from Asian dumping.
📅 Short termPositive sentiment driven by record-high quarterly revenue and profit that significantly beat recent run-rates.
📈 Long termIntegration across the Cumene-Phenol-Acetone chain toward Polycarbonate and downstream chemicals (MIBK/MIBC) provides structural protection against global dumping cycles.
⚠ Risk flags
Margin volatility in Advanced Intermediates due to aggressive global pricing and dumping
High dependence on Phenolics segment for overall company profitability
Potential normalization of import disruptions reducing domestic realization premiums
👀 What to Watch
Track whether high Phenolics spreads and domestic import substitution advantages sustain over coming quarters, alongside execution updates on the downstream Polycarbonate, MIBK, and MIBC projects.
Deepa Jewellers Q2 FY27 Concall: Revenue Up 25% YoY to ₹626 Cr, In-House Facility Commences
Deepa Jewellers released the transcript of its first-ever earnings conference call following Q2 FY27 results. Revenue from operations increased 25% YoY to ₹626 crore, and EBITDA reached ₹45 crore. Total operating volume grew 13% YoY to 809 kgs, driven by a 44% surge in high-margin job work volumes to 318 kgs. The company also announced that executive promoters will draw zero salary starting October 1, 2026, and plans to expand studded jewellery share from 57% to 75% over the next 3-4 quarters.
high confidence
What changedDeepa Jewellers filed its maiden post-listing earnings call transcript, disclosing segment performance, margin metrics, and strategic initiatives.
Why it mattersDemonstrates management's shift toward high-margin job work (~75% EBITDA margin segment) and in-house studded manufacturing, alongside promoter salary waivers to boost profitability.
📅 Short termInformational disclosure providing transparency on Q2 performance and confirming the opening of a second sales office in Chennai by December 2026.
📈 Long termScaling in-house manufacturing and pushing studded jewellery to 75% should help structurally expand margins and support higher working capital efficiency in the B2B jewellery model.
⚠ Risk flags
Working capital intensive business model dependent on consistent liquidity and debt management
Recent drop in studded jewellery share to 57% (from 65% in FY26) caused gross margin pressure in non-job work business
👀 What to Watch
Track the margin trajectory in Q3 FY27 to observe whether the higher mix of job work and planned increase in studded jewellery to 75% offsets recent base margin dilution.
Deepak Nitrite has submitted its standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The meeting commenced at 2:00 PM and concluded at 4:00 PM on October 29, 2026, accompanied by a Limited Review Report from statutory auditors Deloitte Haskins & Sells LLP. Detailed financial figures were not reproduced in the covering transmission letter. Investors will need to refer to the full financial tables to assess performance relative to TTM revenue of Rs 8,575 Cr and recent Q1 FY27 revenue of Rs 2,577.6 Cr.
medium confidence
What changedDeepak Nitrite's board has officially considered and approved the un-audited financial results for Q2 and H1 ended September 30, 2026.
Why it mattersProvides quarterly financial performance indicators against previous quarters, showing whether the top-line momentum from Q1 FY27 is sustained amidst industry-wide pricing headwinds.
Meeting duration: 2:00 P.M. to 4:00 P.M.Financial period ended: 30th September, 2026
📅 Short termMarket focus will shift to the underlying numbers (EBITDA margin, net profit growth) once the complete quarterly disclosure is parsed.
📈 Long termLong-term outlook remains dependent on the commissioning and ramp-up of downstream MIBK, MIBC, and the integrated Polycarbonate project to counter Chinese supply dumping.
⚠ Risk flags
Full numerical tables omitted in the covering document text
Pricing pressures from global supply buildup in Phenolics
👀 What to Watch
Track the detailed standalone and consolidated financial statements and management commentary regarding margin performance in the Phenolics segment and updates on the Polycarbonate expansion.
Deepa Jewellers Reports Q2 FY27 PAT Up 37.1% YoY to ₹37.3 Cr; H1 Revenue Crosses ₹1,056 Cr
Deepa Jewellers released its Q2 and H1 FY27 investor presentation, reporting a 24.6% YoY growth in Q2 revenue to ₹6,256 Mn and a 37.1% YoY increase in PAT to ₹373 Mn. For H1 FY27, revenue reached ₹10,567 Mn (up 30.1% YoY) with PAT rising 31.9% YoY to ₹641 Mn. During the quarter, the company commenced commercial operations at its dedicated in-house manufacturing facility in Hyderabad. Management noted that business follows seasonal trends where H1 accounts for ~40% of annual revenue, with stronger traction expected in H2 supported by IPO proceeds and festive demand.
high confidence
What changedDeepa Jewellers published its detailed Q2 and H1 FY27 investor presentation detailing quarterly financials, manufacturing launch, and balance sheet status post-IPO.
Why it mattersDemonstrates sustained ~30% revenue growth and margin resilience while transitioning from purely external karigars to in-house manufacturing, alongside balance sheet deleveraging.
📅 Short termMarket sentiment should be supported by strong Q2 earnings growth (+37.1% PAT) and lower leverage, though festive demand shifted partially toward H2.
📈 Long termThe shift toward in-house manufacturing in Hyderabad and expansion across regional B2B jewellery accounts could drive structural operating efficiency and margin retention.
⚠ Risk flags
Regional concentration with revenue predominantly driven from Southern Indian states
Customer concentration risk as a B2B supplier reliant on major jewellery retail chains
Working capital intensive operations with high inventories and trade receivables
👀 What to Watch
Track the margin trajectory from the newly operational Hyderabad manufacturing unit and check if H2 FY27 achieves the typical ~60% seasonal revenue contribution.
Deepa Jewellers Limited approved its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported on the deployment of its recent ₹2,500 million fresh issue IPO proceeds, having utilized ₹1,537.80 million up to September 30, 2026, leaving ₹962.20 million unutilized. Of the ₹2,150.00 million allocated for long-term working capital requirements, ₹1,250.00 million has been deployed. The company was recently listed on BSE and NSE on September 08, 2026.
medium confidence
What changedDeepa Jewellers published its first post-listing half-yearly and quarterly financial results and reported on the progress of IPO fund utilization.
Why it mattersProper utilization of working capital funds is critical for the B2B jewellery business model to support inventory growth and scale operations post-IPO.
📅 Short termMarket focus will remain on the detailed earnings metrics and whether the working capital infusion drives sequential revenue growth.
📈 Long termExecution in the B2B jewellery segment and efficient inventory turns using the newly raised equity capital will determine long-term ROCE.
⚠ Risk flags
High working capital intensity inherent to the gold jewellery B2B trade
Detailed P&L figures in the filing extract are partially truncated/garbled
👀 What to Watch
Track the deployment pace of the remaining ₹900.00 million working capital IPO proceeds and monitor working capital turn in subsequent quarterly updates.
ICRA Reaffirms Deepak Fertilisers at [ICRA]AA-, Revises Outlook to Positive for ₹2,186 Cr Loans
ICRA has reaffirmed Deepak Fertilisers and Petrochemicals Corporation Limited's long-term fund-based term loan rating at [ICRA]AA- and revised its outlook from 'Watch with Developing Implications' to 'Positive'. The rating covers ₹2,186.00 crore of term loan facilities. The positive outlook is supported by commencement of gas supplies under the Equinor contract, which stabilizes ammonia output and improves margins, alongside near-complete capex projects. Major capex includes the 376 KTPA TAN project at Gopalpur (₹2,675 crore cost, ~95% complete) and the Dahej nitric acid project (₹1,983 crore cost), both targeted for commissioning in Q3 FY2027.
high confidence
What changedICRA removed Deepak Fertilisers from 'Watch with Developing Implications' and assigned a 'Positive' outlook while reaffirming its [ICRA]AA- rating.
Why it mattersReflects improving operating cash flows and margin expansion from lower gas costs (Equinor contract), and signals potential rating upgrades post-commissioning of large capex projects.
Rated Term Loan Facilities: Rs. 2186.00 croreGopalpur TAN Project Cost: Rs. 2,675 croreNitric Acid Project Capex: Rs. 1,983 croreCombined Capex vs TTM Revenue: ~38.5%
📅 Short termPositive sentiment driver as the removal of rating watch and positive outlook lowers refinancing risk and underscores operational stability from Equinor gas supplies.
📈 Long termCommissioning of ~₹4,658 crore total capex (TAN and nitric acid) in H2 FY2027 is expected to expand capacities, improve operating leverage, and strengthen financial profile from FY2028 onwards.
⚠ Risk flags
Commissioning delays or stabilization headwinds at Gopalpur and Dahej plants
Volatile fertilizer margins due to elevated phosphoric acid costs and regulatory delays in NBS subsidy updates
Pending tax litigations including High Court appeal by Income Tax Department and residual penalty of ₹96.04 crore
👀 What to Watch
Monitor commissioning timelines and production ramp-up for both the Dahej nitric acid plant and Gopalpur TAN facility in Q3/Q4 FY2027, as well as upcoming NBS subsidy announcements.
Deepa Jewellers Q1 FY27 Revenue Up 39% YoY to ₹431.1 Cr, PAT Rises 27% to ₹26.8 Cr
Deepa Jewellers released its Q1 FY27 investor presentation following results, posting revenue from operations of ₹431.1 crore (INR 4,311 Mn), up 39.0% YoY. EBITDA grew 33.9% YoY to ₹38.7 crore with EBITDA margins contracting slightly by 34 bps to 8.98% due to karigar hiring costs. Net profit rose 27.0% YoY to ₹26.8 crore, delivering a diluted EPS of ₹3.26. The company is transitioning from an outsourced model to an in-house manufacturing facility (6,696 sq ft in Hyderabad) and expanding its South India distribution footprint.
high confidence
What changedDeepa Jewellers released its detailed Q1 FY27 investor presentation detailing segmental metrics, manufacturing transition, and regional expansion.
Why it mattersDemonstrates strong topline growth (+39% YoY) and outlines a structural shift towards in-house manufacturing and direct regional distribution, which could protect gross margins long term.
📅 Short termThe market will digest the strong 39% YoY revenue jump against a 20.3% QoQ contraction, which management attributes to jewellery industry seasonality.
📈 Long termTransition to dedicated in-house manufacturing coupled with expansion into Tamil Nadu and Karnataka could structurally improve margin retention and reduce karigar dependency.
⚠ Risk flags
Working capital intensive business model with increasing trade receivables (INR 2,523 Mn in FY26)
Higher finance costs from increased debt to fund inventory
Seasonal QoQ fluctuations in jewellery demand
👀 What to Watch
Track the ramp-up and operational margins of the new Hyderabad manufacturing facility, alongside upcoming regional sales office openings in Chennai, Bangalore, and Coimbatore.
Deepak Nitrite's wholly owned subsidiary, Deepak Chem Tech Limited, has commissioned manufacturing operations of its Chlorination and Specialty chemical plant along with utilities and infrastructure on September 29, 2026, at Dahej, Gujarat. The total capital expenditure incurred for this project is approximately Rs 300 crore as of the commencement date. This capex represents ~9.3% of the company's net worth (Rs 3,215 crore) and ~3.5% of TTM revenue (Rs 8,575 crore). The facility aligns with the group's strategy to deepen vertical integration into downstream specialty chemicals.
high confidence
What changedDeepak Chem Tech Limited commenced commercial manufacturing at its chlorination and specialty chemical plant at Dahej.
Why it mattersAdds higher-margin specialty chemical manufacturing capability, expanding downstream integration and supporting future earnings growth.
Total capex incurred: Rs 300 CroresCapex to Net Worth: ~9.3%Capex to TTM Revenue: ~3.5%Commissioning date: 29th September 2026
📅 Short termPositive sentiment from successful project commissioning without reported delays, though near-term earnings impact depends on ramp-up speed.
📈 Long termEnhances the company's vertical integration and expands the portfolio of higher-value specialty chemicals, mitigating commodity exposure.
⚠ Risk flags
Plant ramp-up delays or initial operational bottlenecks
Exposure to pricing volatility and global demand fluctuations in downstream chemicals
👀 What to Watch
Track the ramp-up schedule and capacity utilization figures in upcoming quarterly updates to gauge revenue and margin contribution from the new specialty facility.
Deepa Jewellers Q1 FY27 Net Profit Rises 27% YoY to ₹267.56 Mn; Revenue Up 39% to ₹4,311.11 Mn
Deepa Jewellers Limited reported its first post-IPO quarterly results for the quarter ended June 30, 2026. Revenue from operations grew 39.0% YoY to ₹4,311.11 million compared to ₹3,100.60 million in Q1 FY26, though it declined sequentially from ₹5,408.54 million in Q4 FY26. Net profit for the period rose 27.0% YoY to ₹267.56 million from ₹210.68 million in Q1 FY26. Basic and diluted EPS stood at ₹3.26 for the quarter on an equity base of ₹164.00 million.
high confidence
What changedDeepa Jewellers reported its unaudited financial results for the quarter ended June 30, 2026, marking its maiden quarterly report following its September 2026 stock exchange listing.
Why it mattersDemonstrates solid YoY top-line and bottom-line expansion for the B2B gold jewellery manufacturer, although revenue and profit saw seasonal sequential softening compared to Q4 FY26.
📅 Short termThe stock will likely digest the maiden post-listing earnings, reflecting steady YoY growth offset by quarter-on-quarter contraction.
📈 Long termLong-term performance will depend on the effective deployment of the ₹2,500 million fresh issue proceeds into working capital and scaling the B2B hallmarked jewellery business.
⚠ Risk flags
Sequential contraction in revenue (-20.3% QoQ) and profit
Working capital intensity inherent to gold jewellery manufacturing
👀 What to Watch
Track subsequent quarters to gauge revenue run-rate and observe the deployment timeline of the ₹2,500 million IPO fresh issue proceeds as per the prospectus objectives.
Deepak Fertilisers Bifurcates Manufacturing Leadership; Appoints Amir Alvi as President Operations
Deepak Fertilisers and Petrochemicals Corp. Ltd. has restructured its manufacturing leadership into two distinct roles effective September 1, 2026. Mr. Amir Alvi, who brings over 36 years of industry experience including roles as COO (Fertilizers) at Coromandel International and 23 years at Tata Chemicals, has been appointed as President - Manufacturing Operations (Senior Management Personnel). Concurrently, Mr. Pandurang Landge, previously President - Manufacturing with 44 years of experience, has been redesignated as President - Manufacturing Excellence & Technology Development.
high confidence
What changedThe company restructured its manufacturing leadership by creating two distinct positions and appointed ex-Coromandel COO Amir Alvi to lead manufacturing operations from September 1, 2026.
Why it mattersSeparating operational plant management from technology development and excellence strengthens executive bandwidth across Deepak Fertilisers' multi-site operations.
Effective date: 1st September, 2026Amir Alvi industry experience: 36+ yearsPandurang Landge industry experience: 44 yearsAmir Alvi tenure at Tata Chemicals: 23 years
📅 Short termNeutral impact on stock price and near-term financials; represents an orderly management restructuring.
📈 Long termStrengthens manufacturing operations and process engineering focus as the company scales its specialty fertiliser and chemical portfolio.
👀 What to Watch
Track operational execution and manufacturing efficiency gains in upcoming quarters as new leadership assumes operational responsibilities.
Deepak Nitrite and DPL Infuse ₹175 Cr in Subsidiary Deepak Chem Tech via 9% OCRPS
Deepak Nitrite Limited (DNL) and its wholly owned subsidiary Deepak Phenolics Limited (DPL) have infused a total of ₹175 Crore into Deepak Chem Tech Limited (DCTL) via 9% Optionally Convertible Redeemable Preference Shares (OCRPS). DNL subscribed to 80 lakh shares (₹80 Crore) while DPL subscribed to 95 lakh shares (₹95 Crore) at ₹100 par value. The capital will support DCTL's ongoing project expenses and general corporate purposes across its chemical plants in Gujarat. DCTL has scaled its turnover rapidly from ₹0.86 Crore in FY24 to ₹172.23 Crore in FY26.
high confidence
What changedDNL and DPL completed an internal capital infusion of ₹175 Crore into wholly owned subsidiary DCTL via 9% OCRPS.
Why it mattersProvides necessary funding to scale DCTL's specialty downstream projects without increasing consolidated external debt.
Total Infusion Amount: ₹175 CroresDNL Direct Infusion: ₹80 CroresDPL Infusion: ₹95 CroresDCTL FY26 Turnover: ₹172.23 CroresInfusion vs TTM Revenue: ~2.0%
📅 Short termNeutral; this is an internal group restructuring/funding event with no immediate impact on consolidated quarterly earnings.
📈 Long termSupports DNL's strategic vertical integration into advanced intermediates and downstream chemistries to diversify away from commodity cycles.
⚠ Risk flags
Project execution timelines and ramp-up risks at DCTL's Gujarat manufacturing sites.
👀 What to Watch
Track the commercialization and revenue ramp-up of DCTL's fluorination, nitric acid, nitration, and hydrogenation projects in upcoming quarterly updates.
₹2,592 Cr Revenue: Deepak Nitrite Reports Record Q1 FY27 Performance and New Project Commissioning
Deepak Nitrite reported a record-breaking Q1 FY27 with consolidated revenue of ₹2,592 crore, a 35% YoY increase. EBITDA margins expanded significantly to 21% from 11% a year ago, leading to a 207% YoY surge in PAT to ₹345 crore. The company is successfully transitioning into an integrated nitrogen platform, with the ammonia-to-amines integration complete. Management confirmed that MIBK, MIBC, and Acetophenone projects are scheduled for commissioning in August 2026, which will further deepen downstream integration.
high confidence
What changedDeepak Nitrite has transitioned from a nitration-focused company to an integrated nitrogen platform and is now moving into high-value downstream products like MIBK and MIBC.
Why it mattersThe shift towards downstream integration and the upcoming Polycarbonate project reduces reliance on commodity chemical cycles and improves structural cost competitiveness against global imports.
Q1 FY27 Revenue: ₹2,592 crQ1 PAT vs TTM PAT: 62.6%EBITDA Margin: 21%Phenolics EBIT Growth (YoY): 254%Advanced Intermediates Revenue: ₹804 cr
📅 Short termThe stock is likely to react positively to the record earnings and the immediate catalyst of new plant commissionings in August 2026.
📈 Long termThe company's strategy to build an integrated advanced material platform, including India's first integrated Polycarbonate project, positions it for structural growth and margin resilience over the next 3-5 years.
⚠ Risk flags
Global oversupply and dumping by Asian producers
Volatility in feedstock prices (Propylene and Benzene)
Execution risk for large-scale greenfield projects
👀 What to Watch
Investors should monitor the successful ramp-up of the MIBK and MIBC plants in Q2 FY27 and track the execution milestones of the large-scale Polycarbonate project. The sustainability of the 21% EBITDA margin amidst global chemical price volatility is a key metric to watch in upcoming quarters.
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited, has commissioned its Methyl Isobutyl Ketone (MIBK) and Methyl Isobutyl Carbinol (MIBC) plant at Dahej, Gujarat. The project involved a capital expenditure of approximately ₹735 Crores, which represents about 22.8% of the company's current net worth (₹3,215 Cr). This commissioning marks a significant move into downstream specialty chemicals, aiming to diversify the product mix and improve margin resilience against global dumping. The plant includes necessary offsite utilities and infrastructure, transitioning the project from the investment phase to the revenue-generation phase.
high confidence
What changedThe company has successfully completed and commissioned a major ₹735 Cr downstream expansion project, moving from construction to production.
Why it mattersThis expansion into MIBK and MIBC reduces reliance on commodity chemicals and provides a hedge against global dumping by moving further down the value chain into specialty applications.
Project Capex: ₹735 CroresCapex vs Net Worth: ~22.8%Capex vs TTM Revenue: ~9.3%Commissioning Date: August 6, 2026
📅 Short termPositive sentiment is expected as the project begins contributing to the top line, potentially improving the revenue run rate from Q3 FY27 onwards.
📈 Long termStructurally significant as it strengthens the company's 'China+1' positioning and vertical integration, creating higher entry barriers in the specialty chemicals segment.
👀 What to Watch
Monitor the capacity utilization ramp-up and the resulting impact on consolidated operating margins (OPM) in the next 2-3 quarters. Investors should also watch for management commentary regarding domestic market share gains against imported MIBK/MIBC.
101% PAT Growth in Q1 FY27; Major TAN and Acid Projects Near Completion
DEEPAKFERT reported its historic best Q1 FY27 results, with PAT doubling to ₹490 cr and revenue growing 22% YoY to ₹3,256 cr. The performance was driven by strong realizations in Technical Ammonium Nitrate (TAN) and Nitric Acid, alongside benefits from the integrated gas-to-ammonia value chain. Net debt leverage improved significantly to 1.4x from 2.86x. Two major capex projects—TAN at Gopalpur (96% complete) and Acids at Dahej (93% complete)—are nearing commissioning, which is expected to drive H2 growth.
high confidence
What changedThe company has transitioned from a heavy capex phase to a realization phase, delivering record quarterly profits while nearing the completion of two major expansion projects.
Why it mattersThe integration of the ammonia value chain and the shift toward specialty/B2C products are structurally improving margins and reducing debt, providing resilience against commodity volatility.
📅 Short termPositive sentiment is expected due to the record earnings and debt reduction, although Q2 may see a seasonal slowdown in mining volumes due to monsoons.
📈 Long termStructural growth is supported by the completion of the TAN and Acid projects, which will expand capacity and improve margins through backward integration and specialty product focus.
⚠ Risk flags
Volatility in raw material prices (Ammonia, Phos Acid)
Geopolitical disruptions in the Middle East and Russia
👀 What to Watch
Monitor the commissioning and capacity ramp-up of the Gopalpur and Dahej facilities in H2 FY27. Investors should also track global ammonia prices (currently ~$600/ton) and potential Russian export bans on FGAN which could impact realizations.
Deepak Nitrite Approves ₹7.50 Dividend and Key Leadership Elevations at 55th AGM
Deepak Nitrite concluded its 55th Annual General Meeting on August 5, 2026, where shareholders approved a dividend of ₹7.50 per share (375% of face value) for FY26. The meeting formalized significant leadership transitions, including the elevation of Mautik Mehta and Meghav Mehta to Deputy Managing Directors for 5-year terms. Additionally, Anant Pande was appointed as Executive Director & CMO, and Sanjay Upadhyay was re-appointed as Group CFO for another 5 years. These moves solidify the management structure as the company pursues its integrated Polycarbonate and downstream chemical projects.
high confidence
What changedThe company has transitioned its leadership team with new Deputy MD roles and a dedicated CMO, while confirming the FY26 dividend payout.
Why it mattersManagement continuity and a clear leadership hierarchy are critical as the company manages a ₹23,720 Cr market cap and navigates global oversupply challenges in the chemical sector.
Dividend per share: ₹7.50Dividend % of Face Value: 375%Deputy MD Appointment Term: 5 yearsEstimated Dividend Payout: ~₹102 CrDividend vs TTM PAT: ~18.5%
📅 Short termThe stock is likely to react neutrally as the AGM proceedings and dividend were largely anticipated by the market.
📈 Long termThe 5-year mandates for the Deputy MDs and CFO provide structural stability for the company's long-term shift toward high-margin downstream products.
⚠ Risk flags
Promoter remuneration levels (Special Resolution)
Global oversupply impacting domestic margins
👀 What to Watch
Investors should monitor the final voting results to check for any significant dissent on promoter remuneration (Resolution 13). The focus remains on the execution timeline of the upcoming Polycarbonate and MIBK/MIBC projects mentioned in the company's growth strategy.
207% PAT Growth: Deepak Nitrite Reports Highest-Ever Quarterly Performance in Q1 FY27
Deepak Nitrite delivered a record-breaking Q1 FY27, with consolidated revenue growing 35% YoY to 2,592 Cr. Profitability saw a massive surge as PAT rose 207% YoY to 345 Cr, driven by a 254% EBIT jump in the Phenolics segment. The company is aggressively pursuing its 2,900 Cr Polycarbonate project, with equipment shipments from Germany already arriving at the Dahej site. EBITDA margins expanded significantly to 21.4% from 11.2% in the year-ago period, reflecting strong operational leverage.
high confidence
What changedThe company has achieved a significant margin breakout, with EBITDA growing 159% YoY, moving past the margin compression seen in FY26.
Why it mattersThe record performance validates the company's vertical integration strategy and its ability to maintain high operating rates (Phenolics) despite global chemical industry volatility.
📅 Short termThe stock is likely to react positively to the substantial earnings beat and the 'highest-ever' quarterly performance milestone.
📈 Long termStructural growth is underpinned by the 2,900 Cr downstream expansion into Polycarbonates, which aims to substitute imports and deepen the value chain.
⚠ Risk flags
Geopolitical tensions affecting logistics costs
Pricing uncertainty in chemical intermediates
Execution risk for the large-scale Polycarbonate project
👀 What to Watch
Watch for the execution timeline of the 165,000 MT/yr Polycarbonate plant and the impact of the 15-year Petronet LNG agreement on long-term feedstock cost stability.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
🎁 Limited-time offer for early supporters
Our AI stock analytics, free on Telegram & WhatsApp
⚡ We track 3500+ companies instantly. As soon as a filing hits the NSE exchange, our AI reads it, summarizes it and tells you the impact in seconds.
Paid platforms charge ₹1,00,000+ a year for AI analytics like this. Join our channels and get it free.